GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (XSWX:JNJ) » Definitions » Cyclically Adjusted PB Ratio

Johnson & Johnson (XSWX:JNJ) Cyclically Adjusted PB Ratio : (As of May. 05, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Johnson & Johnson Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Johnson & Johnson Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Johnson & Johnson's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson Cyclically Adjusted PB Ratio Chart

Johnson & Johnson Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.62 5.98 6.07 5.89 5.12

Johnson & Johnson Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.10 5.40 5.05 5.12 5.20

Competitive Comparison of Johnson & Johnson's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - General subindustry, Johnson & Johnson's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Johnson & Johnson's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Johnson & Johnson's Cyclically Adjusted PB Ratio falls into.



Johnson & Johnson Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Johnson & Johnson's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Johnson & Johnson's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=23.635/129.4194*129.4194
=23.635

Current CPI (Mar. 2024) = 129.4194.

Johnson & Johnson Quarterly Data

Book Value per Share CPI Adj_Book
201406 24.770 100.560 31.879
201409 25.594 100.428 32.983
201412 24.443 99.070 31.931
201503 23.959 99.621 31.126
201506 23.944 100.684 30.778
201509 25.146 100.392 32.417
201512 25.698 99.792 33.327
201603 25.902 100.470 33.365
201606 25.665 101.688 32.664
201609 26.012 101.861 33.050
201612 26.523 101.863 33.698
201703 26.141 102.862 32.890
201706 25.930 103.349 32.471
201709 26.520 104.136 32.959
201712 22.135 104.011 27.542
201803 22.357 105.290 27.481
201806 23.211 106.317 28.255
201809 23.322 106.507 28.339
201812 22.262 105.998 27.181
201903 22.211 107.251 26.802
201906 22.731 108.070 27.222
201909 21.917 108.329 26.184
201912 22.198 108.420 26.497
202003 22.337 108.902 26.545
202006 22.759 108.767 27.080
202009 22.410 109.815 26.411
202012 21.355 109.897 25.149
202103 23.253 111.754 26.929
202106 23.994 114.631 27.089
202109 24.633 115.734 27.546
202112 25.897 117.630 28.493
202203 26.376 121.301 28.141
202206 28.141 125.017 29.132
202209 27.581 125.227 28.504
202212 27.180 125.222 28.091
202303 24.915 127.348 25.320
202306 25.703 128.729 25.841
202309 24.341 129.860 24.259
202312 22.593 129.419 22.593
202403 23.635 129.419 23.635

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Johnson & Johnson  (XSWX:JNJ) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Johnson & Johnson Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Johnson & Johnson's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Johnson & Johnson (XSWX:JNJ) Business Description

Address
One Johnson and Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.